Literature DB >> 19660871

Vitamin D, nervous system and aging.

P Tuohimaa1, T Keisala, A Minasyan, J Cachat, A Kalueff.   

Abstract

This is a mini-review of vitamin D(3), its active metabolites and their functioning in the central nervous system (CNS), especially in relation to nervous system pathologies and aging. The vitamin D(3) endocrine system consists of 3 active calcipherol hormones: calcidiol (25OHD(3)), 1alpha-calcitriol (1alpha,25(OH)2D(3)) and 24-calcitriol (24,25(OH)2D(3)). The impact of the calcipherol hormone system on aging, health and disease is discussed. Low serum calcidiol concentrations are associated with an increased risk of several chronic diseases including osteoporosis, cancer, diabetes, autoimmune disorders, hypertension, atherosclerosis and muscle weakness all of which can be considered aging-related diseases. The relationship of many of these diseases and aging-related changes in physiology show a U-shaped response curve to serum calcidiol concentrations. Clinical data suggest that vitamin D(3) insufficiency is associated with an increased risk of several CNS diseases, including multiple sclerosis, Alzheimer's and Parkinson's disease, seasonal affective disorder and schizophrenia. In line with this, recent animal and human studies suggest that vitamin D insufficiency is associated with abnormal development and functioning of the CNS. Overall, imbalances in the calcipherol system appear to cause abnormal function, including premature aging, of the CNS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19660871     DOI: 10.1016/j.psyneuen.2009.07.003

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  19 in total

1.  1,25 Dihydroxyvitamin D3 uptake is localized at caveolae and requires caveolar function.

Authors:  Rachel J Schaefer; Jeremy C Bonor; Madhura S Joglekar; Kenneth L van Golen; Anja G Nohe
Journal:  J Biomed Nanotechnol       Date:  2013-10       Impact factor: 4.099

Review 2.  Dysregulation of neural calcium signaling in Alzheimer disease, bipolar disorder and schizophrenia.

Authors:  Michael J Berridge
Journal:  Prion       Date:  2012-08-16       Impact factor: 3.931

3.  Critique of the U-shaped serum 25-hydroxyvitamin D level-disease response relation.

Authors:  William B Grant
Journal:  Dermatoendocrinol       Date:  2009-11

4.  Decrease in age-related tau hyperphosphorylation and cognitive improvement following vitamin D supplementation are associated with modulation of brain energy metabolism and redox state.

Authors:  T L Briones; H Darwish
Journal:  Neuroscience       Date:  2014-01-08       Impact factor: 3.590

5.  Quantification of 1α,25-dihydroxy vitamin D by immunoextraction and liquid chromatography-tandem mass spectrometry.

Authors:  Frederick G Strathmann; Thomas J Laha; Andrew N Hoofnagle
Journal:  Clin Chem       Date:  2011-07-18       Impact factor: 8.327

Review 6.  Calcium regulation of neural rhythms, memory and Alzheimer's disease.

Authors:  Michael J Berridge
Journal:  J Physiol       Date:  2013-06-10       Impact factor: 5.182

Review 7.  Vitamin D, reactive oxygen species and calcium signalling in ageing and disease.

Authors:  Michael J Berridge
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-08-05       Impact factor: 6.237

8.  Reply to W.B. Grant 'Re: Vitamin D deficiency among northern Native Peoples'.

Authors:  Peter Frost
Journal:  Int J Circumpolar Health       Date:  2012-04-24       Impact factor: 1.228

9.  Vitamin D deficiency among northern Native Peoples: a real or apparent problem?

Authors:  Peter Frost
Journal:  Int J Circumpolar Health       Date:  2012-03-19       Impact factor: 1.228

10.  The psychotropic effect of vitamin D supplementation on schizophrenia symptoms.

Authors:  Aras Neriman; Yilmaz Hakan; Ucuncu Ozge
Journal:  BMC Psychiatry       Date:  2021-06-15       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.